Active BE 0797.679.993Private limited company

STPharma

Van Souststraat 262a ·1070 Anderlecht, Belgium· 3 yrs active

Sector: Wholesale of other household goods (46499)

Conclusion Checked

The computed 12-month bankruptcy probability of STPharma is 2.8% (moderate). The 2025 annual accounts show equity of €27k and a net result of €635. Its solvency ranks better than 90% of 4735 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 2 annual accounts.

Key figures

Equity	€27k
Net result	€635
Better than sector	90%
Active	3 yrs

Financial profile 5 of 5 axes measured · computed by Checked

69 / 100

Strong profile, led by solvency.

All 5 axes are computed from data Checked has read.

Health 86

Profitability 12

Solvency 100

Growth 52

Stability 94

Bankruptcy probability (12 mo) Checked model v1 · free

2.8% Moderate

0%0,5%1,5%4%10%≥25%

How do we compute this?

Risk Assessment rule-based

0 / 100

Low risk

Trust signals 2 signals

More than 3 years active

Founded in 2023, past the statistically most fragile first 3 years.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags0 events

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Checked score FY 2025 · computed

86 / 100 Excellent

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Indicative credit limit

€3k

estimate, not credit advice

Score history

86 2024

86 2025

purely financial, excl. current insolvency signals

Score components

Liquidity Current ratio 6.35 (≥ 1.5) +10

Quick ratio Quick ratio 5.81 (≥ 1.0) +5

Leverage Debt/equity 0.17 (< 1.0) +10

Profitability ROE 2% +3

Interest coverage Interest coverage 15.3× (≥ 3×) +8

Profit trend Net profit down YoY -3

Equity growth Equity growing YoY +3

Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Financial overview2 NBB filings

Annual accounts filed on 13-04-2026 with the NBB · fiscal year 2025 · full schema

Operating resultNet result

Sector comparison

Fiscal year 2025 · NACE 46, Wholesale trade · compared within the same schema type (full schema)

Metric	This company	Sector median	Position in the sector
Solvency	85.7%	45.7%	better than 90% of 4735 sector peers
Net result	€635	€116k	better than 24% of 4732 sector peers
Equity	€27k	€1.64M	better than 8% of 4737 sector peers
Gross operating margin	€3k	€354k	better than 10% of 2546 sector peers
Total assets	€31k	€4.25M	better than 5% of 4735 sector peers

EBITDA

€2k

-46.6% 24-25

Net profit

€635

-50.7% 24-25

Cash flow

€2k

-42.8% 24-25

Total assets

€31k

-11.2% 24-25

Equity

€27k

+2.4% 24-25

Working capital

€22k

+11.2% 24-25

Income taxes

€37

-92.6% 24-25

Debt

€4k

-50.7% 24-25

Debt ≤ 1y

€4k

-52.7% 24-25

Current ratio

6.35

+93.9% 24-25

Quick ratio

5.81

+77.2% 24-25

Solvency

85.7%

+15.4% 24-25

Debt / equity

0.17

-51.9% 24-25

ROE

2.4%

-51.8% 24-25

ROA

2.0%

-44.4% 24-25

Interest coverage

15.29

-58.9% 24-25

Figures by fiscal year and ratios

Change versus the prior fiscal year, coloured by direction (green = favourable).

Fiscal year	2025 Δ	2024 Δ
Deposit	full schema	full schema
Revenue	-	-
EBITDA	-46.6%	-
Net profit	-50.7%	-
Cash flow	-42.8%	-
Staff costs	-	-
Income taxes	-92.6%	-
Dividends	-	-
Total assets	-11.2%	-
Equity	+2.4%	-
Debt	-50.7%	-
of which ≤ 1y	-52.7%	-
of which > 1y	-	-
Working capital	+11.2%	-
Employees (FTE)	-	-

Ratios (computed)

	2025	2024
Current ratio	6.35	3.28
Quick ratio	5.81	3.28
Working capital ratio	70.8%	56.5%
Solvency	85.7%	74.3%
Debt / equity	0.17	0.35
Long-term debt ratio	-	-
Interest coverage	15.29	37.25
Gross margin	-	-
Net margin	-	-
ROA	2.0%	3.6%
ROE	2.4%	4.9%
EBITDA margin	-	-
Days sales outstanding	-	-
Days payable outstanding	-	-
Inventory turnover	-	-
Days inventory (DSI)	-	-

Balance-sheet composition 2025

Assets

Fixed assets €5k · 16.0% Current assets €26k · 84.0%

Equity & liabilities

Equity €27k · 85.7% Debt €4k · 14.3%

Full annual accounts (22 line items)

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2025	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€31k	€35k
Fixed assets	21/28	€5k	€7k
Intangible fixed assets	21	€5k	€7k
Current assets	29/58	€26k	€29k
Stocks & contracts in progress	3	€2k	-
Amounts receivable within one year	40/41	€9k	€3k
Cash & bank	54/58	€15k	€26k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€31k	€35k
Equity	10/15	€27k	€26k
Contributions / capital	10/11	€25k	€25k
Accumulated profits (losses)	14	€2k	€1k
Amounts payable	17/49	€4k	€9k
Amounts payable within one year	42/48	€4k	€9k
Trade debts payable within one year	44	€4k	€8k
Income statement
Gross operating margin	9900	€3k	€6k
Operating result	9901	€816	€2k
Financial income	75	€13	-
Financial charges	65	€158	€121
Result before taxes	9903	€672	€2k
Income taxes	67/77	€37	€500
Net result for the period	9904	€635	€1k
Result to be appropriated	9905	€635	€1k

Legal Structure

NACE primary	Wholesale of other household goods(46499)
Legal form	Private limited company(610)
Incorporation	26-01-2023
Status	Active
Postal code	1070

Establishment units 1 location

STPharma

Van Souststraat 262a, 1070 AnderlechtWholesale trade

since 20232.341.322.751

Real-estate footprint Source: CBE × cadastre

Brussels 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
21302A0048/00M006	Brussels	168 m²	1 · 143 m²	16.3 m · 4 fl.

Methodology

via registered seat: 1

1 of 1 parcel with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Updates 2 events

All 2Filings 2

Next filing, fiscal year 2026, expected by 31-05-2027

2026

13-04

NBB filing Annual accounts filed

fiscal year 2025 · full schema

2025

09-05

NBB filing Annual accounts filed

fiscal year 2024 · full schema

NBB filing

Belgian State Gazette reading coverage 0 of 1 acts read

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Credit advice verdict per customer and amount

Company registry (CBE) Crossroads Bank

Activities

Wholesale of other household goods46499Agents in the wholesale of furniture, household goods and hardware46150Wholesale of perfume and cosmetics46450Wholesale of pharmaceutical and medical goods46460Retail sale of cosmetics and toilet articles47750

Names & trade names

Legal nameFR

STPharma

Similar companies Comparable size · 724 of 1,164 companies in this sector with filed accounts

COFICOS BE 0886.173.786 · Theux

LIZANI GROUP BE 0676.848.677 · Sint-Joost-ten-Node

RENOBA BE 0505.690.593 · Sint-Pieters-Woluwe

MT GGI BE 0697.595.690 · Boom

VICI PRODUCTS BE 0475.497.760 · Overijse